Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of zinc-releasing three-dimensional bioactive glass scaffolds and their effect on human adipose stem cell proliferation and osteogenic differentiation.
Haimi S, Gorianc G, Moimas L, Lindroos B, Huhtala H, Räty S, Kuokkanen H, Sándor GK, Schmid C, Miettinen S, Suuronen R. Haimi S, et al. Among authors: schmid c. Acta Biomater. 2009 Oct;5(8):3122-31. doi: 10.1016/j.actbio.2009.04.006. Epub 2009 Apr 16. Acta Biomater. 2009. PMID: 19428318
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cells.
Rothfuß C, Baumann T, Donakonda S, Brauchle B, Marcinek A, Urban C, Mergner J, Pedde AM, Hirschberger A, Krupka C, Neumann AS, Hänel G, Merten C, Öllinger R, Hecker JS, Bauer T, Schmid CR, Götze KS, Altomonte J, Bücklein VL, Jacobs R, Rad R, Dawid C, Simeoni L, Schraven B, Pichlmair A, Subklewe M, Knolle PA, Böttcher JP, Höchst B. Rothfuß C, et al. Among authors: schmid cr. Blood. 2025 Jan 21:blood.2024025706. doi: 10.1182/blood.2024025706. Online ahead of print. Blood. 2025. PMID: 39840945
In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers.
Atzler M, Baudrexler T, Amberger DC, Rogers N, Rabe A, Schmohl J, Wang R, Rank A, Schutti O, Hirschbühl K, Inngjerdingen M, Deen D, Eiz-Vesper B, Schmid C, Schmetzer HM. Atzler M, et al. Among authors: schmid c. Int J Mol Sci. 2024 Dec 16;25(24):13469. doi: 10.3390/ijms252413469. Int J Mol Sci. 2024. PMID: 39769232 Free PMC article.
1,827 results